Tyagi, RahulMaddirala, Amarendar ReddyElfawal, MostafaFischer, ChelseaBulman , Christina A.Rosa, Bruce A.Gao, XinChugani, RyanZhou, MingzhouHelander, JonBrindley, Paul JTseng, Chih-ChungGreig, Iain RSakanari, JudyWildman, Scott A.Aroian, RaffiJanetka, James W.Mitreva, Makedonka2019-05-012019-05-012018-07-13Tyagi, R, Maddirala, A R, Elfawal, M, Fischer, C, Bulman , C A, Rosa, B A, Gao, X, Chugani, R, Zhou, M, Helander, J, Brindley, P J, Tseng, C-C, Greig, I R, Sakanari, J, Wildman, S A, Aroian, R, Janetka, J W & Mitreva, M 2018, 'Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of Anthelmintics', ACS Infectious Diseases, vol. 4, no. 7, pp. 1130–1145. https://doi.org/10.1021/acsinfecdis.8b000902373-8227ORCID: /0000-0003-0338-8664/work/48201812ORCID: /0000-0003-0603-3383/work/65549938http://hdl.handle.net/2164/12228We thank Qi Wang for her technical assistance related to clustering compounds and identifying representatives for screening. This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) grant AI081803 to M.M. The study was also partly supported by NIAID grant AI056189 to R.V.A.162253282engParasitic nematodeshookwormwhipwormfilarial nematodewhole worm assayin vitroin vivotarget class repurposingcarnitine palmitoyltransferase (CPT)bioaccumulationanthelminticR Medicine (General)R1Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of AnthelminticsJournal article10.1021/acsinfecdis.8b0009047